What is CAR T-cell therapy?
CAR T-cell therapy is a novel form of immunotherapy to treat cancer using a patient’s own T-cells which are collected via leukapheresis or T-cells from a donor. In Europe, patients can be treated with CAR T-cell therapy as part of standard of care or by participating in a clinical trial.
Animation from Mofitt Cancer Center to explain CAR T-cell therapy.
For more from Mofitt Cancer Center, click here.
Animation from the Children’s Hospital of Philadelphia. For more from the hospital, click here.
Currently, only CAR T-cell therapies using patients’ own T-cells are available as standard of care to treat hematologic cancers in Europe (i.e. not as part of a clinical trial). Although often only a single infusion with CAR T-cells is needed, the treatment trajectory is intensive and consists of several treatment phases. You can read more about the phases here.
Further information
